✦ LIBER ✦

Cetuximab plus XELIRI or XELOX for First-Line Therapy of Metastatic Colorectal Cancer

✍ Scribed by Nicolas Moosmann; Volker Heinemann

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cetuximab plus FOLFIRI as a first-line t

✍ Daniel G. Haller 📂 Article 📅 2012 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 100 KB

703 PUBLICATION Phase II multicenter stu

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 267 KB

Continuing Single-Agent Bevacizumab as M

✍ Diaz-Rubio, E.; Pietrantonio, F.; de Braud, F. 📂 Article 📅 2012 🏛 Alphamed Press 🌐 English ⚖ 192 KB

Medical oncology: Second-line XELOX or F

✍ Teitelbaum, Ursina R.; Haller, Daniel G. 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 151 KB

XELOX vs FOLFOX-4 as first-line therapy

✍ Cassidy, J; Clarke, S; Díaz-Rubio, E; Scheithauer, W; Figer, A; Wong, R; Koski, 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 347 KB

PCN3 Cetuximab for the First-Line Treatm

✍ Ubago, R.; Castillo, M.A.; Flores, S.; Rodriguez, R.; Beltran, C. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB